Elutia (ELUT) Competitors $3.20 -0.01 (-0.31%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ELUT vs. SIGA, TKNO, ZVRA, ATXS, PRTC, MBX, CYRX, KMDA, ABVX, and KODShould you be buying Elutia stock or one of its competitors? The main competitors of Elutia include SIGA Technologies (SIGA), Alpha Teknova (TKNO), Zevra Therapeutics (ZVRA), Astria Therapeutics (ATXS), PureTech Health (PRTC), MBX Biosciences (MBX), Cryoport (CYRX), Kamada (KMDA), ABIVAX Société Anonyme (ABVX), and Kodiak Sciences (KOD). These companies are all part of the "pharmaceutical products" industry. Elutia vs. SIGA Technologies Alpha Teknova Zevra Therapeutics Astria Therapeutics PureTech Health MBX Biosciences Cryoport Kamada ABIVAX Société Anonyme Kodiak Sciences SIGA Technologies (NASDAQ:SIGA) and Elutia (NASDAQ:ELUT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation, community ranking and institutional ownership. Is SIGA or ELUT more profitable? SIGA Technologies has a net margin of 49.33% compared to Elutia's net margin of -218.72%. SIGA Technologies' return on equity of 49.06% beat Elutia's return on equity.Company Net Margins Return on Equity Return on Assets SIGA Technologies49.33% 49.06% 38.72% Elutia -218.72%N/A -142.61% Does the MarketBeat Community prefer SIGA or ELUT? Elutia received 5 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 100.00% of users gave Elutia an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote. CompanyUnderperformOutperformSIGA TechnologiesOutperform Votes523.81% Underperform Votes1676.19% ElutiaOutperform Votes10100.00% Underperform VotesNo Votes Do analysts rate SIGA or ELUT? Elutia has a consensus price target of $10.00, indicating a potential upside of 212.50%. Given Elutia's stronger consensus rating and higher possible upside, analysts clearly believe Elutia is more favorable than SIGA Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SIGA Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Elutia 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger valuation & earnings, SIGA or ELUT? SIGA Technologies has higher revenue and earnings than Elutia. Elutia is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSIGA Technologies$139.92M3.17$68.07M$1.205.18Elutia$24.75M4.47-$37.66M-$2.61-1.23 Does the media favor SIGA or ELUT? In the previous week, Elutia had 2 more articles in the media than SIGA Technologies. MarketBeat recorded 2 mentions for Elutia and 0 mentions for SIGA Technologies. Elutia's average media sentiment score of 0.51 beat SIGA Technologies' score of -0.33 indicating that Elutia is being referred to more favorably in the news media. Company Overall Sentiment SIGA Technologies Neutral Elutia Positive Which has more risk and volatility, SIGA or ELUT? SIGA Technologies has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Comparatively, Elutia has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Do insiders & institutionals have more ownership in SIGA or ELUT? 55.4% of SIGA Technologies shares are owned by institutional investors. Comparatively, 74.0% of Elutia shares are owned by institutional investors. 1.5% of SIGA Technologies shares are owned by company insiders. Comparatively, 40.8% of Elutia shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryElutia beats SIGA Technologies on 10 of the 18 factors compared between the two stocks. Get Elutia News Delivered to You Automatically Sign up to receive the latest news and ratings for ELUT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELUT vs. The Competition Export to ExcelMetricElutiaBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$110.59M$2.96B$5.20B$9.14BDividend YieldN/A1.91%5.13%4.02%P/E Ratio-1.2344.1187.2517.09Price / Sales4.47275.871,263.9177.22Price / CashN/A192.9043.7736.04Price / Book-1.933.965.314.79Net Income-$37.66M-$41.02M$122.54M$224.99M7 Day Performance9.59%1.13%1.44%2.37%1 Month Performance-33.88%-1.72%2.51%4.40%1 Year Performance-19.80%-2.23%25.32%20.10% Elutia Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELUTElutia3.1088 of 5 stars$3.20-0.3%$10.00+212.5%-19.8%$110.59M$24.75M-1.23180SIGASIGA Technologies1.7107 of 5 stars$6.06-2.4%N/A+21.2%$432.71M$173.73M5.0540TKNOAlpha Teknova0.5415 of 5 stars$8.08+0.2%$5.00-38.1%+175.9%$430.73M$36.35M-10.92240ZVRAZevra Therapeutics2.0132 of 5 stars$8.06-0.6%$21.57+167.6%+40.7%$430.21M$24.49M-4.0920ATXSAstria Therapeutics1.5027 of 5 stars$7.46+0.1%$25.60+243.2%-3.0%$421.00MN/A-3.5730Positive NewsPRTCPureTech Health1.7339 of 5 stars$17.49-0.6%$45.00+157.3%-23.3%$418.75M$3.33M0.00100Gap DownHigh Trading VolumeMBXMBX BiosciencesN/A$12.46-9.0%$37.25+199.0%N/A$416.38MN/A0.0036Gap DownCYRXCryoport3.4174 of 5 stars$8.39-1.4%$12.29+46.4%-48.1%$414.72M$233.26M-2.481,170Short Interest ↓KMDAKamada3.9994 of 5 stars$7.20-2.8%$14.50+101.4%+22.0%$413.86M$158.38M25.71360ABVXABIVAX Société Anonyme2.149 of 5 stars$6.50+1.9%$38.67+494.9%-46.8%$411.76MN/A0.0061KODKodiak Sciences3.7109 of 5 stars$7.81-6.1%$8.00+2.4%+129.8%$410.99MN/A-2.1490Short Interest ↑ Related Companies and Tools Related Companies SIGA Competitors TKNO Competitors ZVRA Competitors ATXS Competitors PRTC Competitors MBX Competitors CYRX Competitors KMDA Competitors ABVX Competitors KOD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ELUT) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elutia Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elutia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELUT Stock Alerts